Mebendazole Supplier-Buyer Network — Trade Flow Analysis

Name: Mebendazole Supplier-Buyer Trade Network Dataset — 259+ Indian Exporters, 11+ Importers, 108+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Mebendazole supplier network, Mebendazole buyers, pharmaceutical export India, Mebendazole trade data

TransData Nexus

Mebendazole

India Pharmaceutical Trade Intelligence

$13.7M259 Suppliers108 CountriesHS 30049099

ExportsIndia → CAMEROON22.4%India → FRANCE14.3%

ImportsUNITED STATES → India$347.0K ISRAEL → India$34.0K

#1 Supplier: KROSYL PHARMACEUTICALS #1 Buyer: PLANET PHARMA

Who Supplies Mebendazole? Top Manufacturers & Buyers 2026 — KROSYL PHARMACEUTICALS PRIVATE LIMITED Leads | TransData Nexus | TransData Nexus

1KROSYL PHARMACEUTICALS PRIVATE LIMITED

KROSYL PHARMACEUTICALS PRIVATE LIMITED is the first-largest Mebendazole exporter from India, with a market share of 19.5% and a total export value of $2.7M across 3 shipments. Their average shipment value of $894.6K is above the market average of $4.7K, suggesting premium or bulk contract pricing.

KROSYL PHARMACEUTICALS PRIVATE LIMITED serves 1 named buyer in our database. TO THE ORDER (CAMERO is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• TO THE ORDER (CAMERO — $2.7M across 3 shipments (100.0% of this supplier's total exports)

Key Insight: KROSYL PHARMACEUTICALS PRIVATE LIMITED's per-shipment value of $894.6K is 18991% above the market average of $4.7K, consistent with large-order contracts or value-added formulations.

2CADILA PHARMACEUTICALS LIMITED

CADILA PHARMACEUTICALS LIMITED is the second-largest Mebendazole exporter from India, with a market share of 12.3% and a total export value of $1.7M across 111 shipments. Their average shipment value of $15.2K is above the market average of $4.7K, suggesting premium or bulk contract pricing.

CADILA PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• RANBAXY PHARMACEUTICALS PTY LIMITED — $552.8K across 36 shipments (32.8% of this supplier's total exports)

• EURIMEX PHARMA — $492.6K across 32 shipments (29.3% of this supplier's total exports)

• SUNSHINE HEALTHCARE LANKA LIMITED — $239.7K across 16 shipments (14.2% of this supplier's total exports)

• EURIMEX PHARMA — $201.9K across 13 shipments (12.0% of this supplier's total exports)

• INTERPHARMA INDUSTRIES LIMITED — $196.3K across 13 shipments (11.7% of this supplier's total exports)

Key Insight: CADILA PHARMACEUTICALS LIMITED's per-shipment value of $15.2K is 224% above the market average of $4.7K, consistent with large-order contracts or value-added formulations.

3LINCOLN PHARMACEUTICALS LTD

LINCOLN PHARMACEUTICALS LTD is the third-largest Mebendazole exporter from India, with a market share of 8.3% and a total export value of $1.1M across 22 shipments. Their average shipment value of $51.8K is above the market average of $4.7K, suggesting premium or bulk contract pricing.

LINCOLN PHARMACEUTICALS LTD serves 1 named buyer in our database. PLANET PHARMA is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• PLANET PHARMA — $1.1M across 22 shipments (100.0% of this supplier's total exports)

Key Insight: LINCOLN PHARMACEUTICALS LTD's per-shipment value of $51.8K is 1005% above the market average of $4.7K, consistent with large-order contracts or value-added formulations.

4J B CHEMICALS AND PHARMACEUTICALS LIMITED

J B CHEMICALS AND PHARMACEUTICALS LIMITED is the fourth-largest Mebendazole exporter from India, with a market share of 2.0% and a total export value of $275.3K across 94 shipments. Their average shipment value of $2.9K is below the market average of $4.7K, reflecting a high-volume, competitive pricing strategy.

J B CHEMICALS AND PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• INOVA PHARMACEUTICALS(AUSTRALIA) PT — $94.1K across 32 shipments (34.2% of this supplier's total exports)

• Y LIMITED 5 MILLNER — $77.2K across 26 shipments (28.0% of this supplier's total exports)

• INOVA PHARMACEUTICALS(AUSTRALIA) PT — $51.8K across 18 shipments (18.8% of this supplier's total exports)

• MERCYMED TRADING PLC — $33.2K across 11 shipments (12.1% of this supplier's total exports)

• AL-HAITHAM CHEMICALS — $19.0K across 6 shipments (6.9% of this supplier's total exports)

Key Insight: J B CHEMICALS AND PHARMACEUTICALS LIMITED operates with high shipment frequency (94 shipments) at a per-shipment value of $2.9K, indicating a broad distribution network with many smaller, regular orders.

5PRASHI PHARMA PRIVATE LIMITED

PRASHI PHARMA PRIVATE LIMITED is the fifth-largest Mebendazole exporter from India, with a market share of 1.5% and a total export value of $205.1K across 32 shipments. Their average shipment value of $6.4K is above the market average of $4.7K, suggesting premium or bulk contract pricing.

PRASHI PHARMA PRIVATE LIMITED serves 1 named buyer in our database. STE PRINCE PHARMA SARL is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• STE PRINCE PHARMA SARL — $205.1K across 32 shipments (100.0% of this supplier's total exports)

Key Insight: PRASHI PHARMA PRIVATE LIMITED's per-shipment value of $6.4K is 37% above the market average of $4.7K, consistent with large-order contracts or value-added formulations.

6BEID HEALTHCARE PRIVATE LIMITED

BEID HEALTHCARE PRIVATE LIMITED is the fifth-largest Mebendazole exporter from India, with a market share of 0.3% and a total export value of $39.0K across 40 shipments. Their average shipment value of $976 is below the market average of $4.7K, reflecting a high-volume, competitive pricing strategy.

BEID HEALTHCARE PRIVATE LIMITED serves 1 named buyer in our database. CONSULTING PHARMA FORMULATIONS (CPF is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• CONSULTING PHARMA FORMULATIONS (CPF — $39.0K across 40 shipments (100.0% of this supplier's total exports)

Key Insight: BEID HEALTHCARE PRIVATE LIMITED operates with high shipment frequency (40 shipments) at a per-shipment value of $976, indicating a broad distribution network with many smaller, regular orders.

1Cameroon

Cameroon ranks as the first-largest destination for Mebendazole imports from India, with a total trade value of $3.1M across 0 shipments — representing a 22.4% share of all Mebendazole exports. The average shipment value of $3.1M is above the global average of $4.7K, indicating high-value procurement contracts or branded formulations.

Key Insight: Cameroon's per-shipment average of $3.1M (65588% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Cameroon is a key market for Mebendazole imports from India.

Primary Market

Secondary Market

2France

France ranks as the second-largest destination for Mebendazole imports from India, with a total trade value of $2.0M across 52 shipments — representing a 14.3% share of all Mebendazole exports. The average shipment value of $37.9K is above the global average of $4.7K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.

Named Mebendazole importers in France: PLANET PHARMA is the largest buyer, accounting for 61.9% ($1.2M) of this market's total imports.

• PLANET PHARMA — $1.2M (61.9% of France's total)

• EURIMEX PHARMA — $492.6K (25.0% of France's total)

• EURIMEX PHARMA. — $201.9K (10.3% of France's total)

Key Insight: France's per-shipment average of $37.9K (708% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

France is a key market for Mebendazole imports from India.

Primary Market

Secondary Market

3South Africa

South Africa ranks as the third-largest destination for Mebendazole imports from India, with a total trade value of $1.2M across 35 shipments — representing a 8.8% share of all Mebendazole exports. The average shipment value of $34.5K is above the global average of $4.7K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.

Named Mebendazole importers in South Africa: RANBAXY PHARMACEUTICALS (PTY) LTD. is the largest buyer, accounting for 45.7% ($552.8K) of this market's total imports.

• RANBAXY PHARMACEUTICALS (PTY) LTD. — $552.8K (45.7% of South Africa's total)

• RANBAXY PHARMACEUTICALS PTY LTD — $323.9K (26.8% of South Africa's total)

• RANBAXY PHARMACEUTICALS (PTY) LTD — $169.0K (14.0% of South Africa's total)

Key Insight: South Africa's per-shipment average of $34.5K (637% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

South Africa is a key market for Mebendazole imports from India.

Primary Market

Secondary Market

4Sri Lanka

Sri Lanka ranks as the fourth-largest destination for Mebendazole imports from India, with a total trade value of $717.0K across 14 shipments — representing a 5.2% share of all Mebendazole exports. The average shipment value of $51.2K is above the global average of $4.7K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Mebendazole importers in Sri Lanka: SUNSHINE HEALTHCARE LANKA LIMITED is the largest buyer, accounting for 34.5% ($247.5K) of this market's total imports.

• SUNSHINE HEALTHCARE LANKA LIMITED — $247.5K (34.5% of Sri Lanka's total)

Key Insight: Sri Lanka's per-shipment average of $51.2K (993% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Sri Lanka is a key market for Mebendazole imports from India.

Primary Market

Secondary Market

5Congo Dr

Congo Dr ranks as the fifth-largest destination for Mebendazole imports from India, with a total trade value of $679.9K across 42 shipments — representing a 4.9% share of all Mebendazole exports. The average shipment value of $16.2K is above the global average of $4.7K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Mebendazole importers in Congo Dr: STE PRINCE PHARMA SARL is the largest buyer, accounting for 66.5% ($452.0K) of this market's total imports.

• STE PRINCE PHARMA SARL — $452.0K (66.5% of Congo Dr's total)

Key Insight: Congo Dr's per-shipment average of $16.2K (245% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Congo Dr is a key market for Mebendazole imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Mebendazole.
2.Flow Mapping: 259 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 2,932 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 108 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

2,932 Verified Shipments

259 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Mebendazole

Mebendazole

Who Supplies Mebendazole? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Mebendazole? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Mebendazole Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1KROSYL PHARMACEUTICALS PRIVATE LIMITED

2CADILA PHARMACEUTICALS LIMITED

3LINCOLN PHARMACEUTICALS LTD

4J B CHEMICALS AND PHARMACEUTICALS LIMITED

5PRASHI PHARMA PRIVATE LIMITED

6BEID HEALTHCARE PRIVATE LIMITED

From Indian Factories to Global Pharmacies — How Mebendazole Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Mebendazole Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1Cameroon

2France

3South Africa

4Sri Lanka

5Congo Dr

People Also Ask — Mebendazole Supplier & Trade Network

Mebendazole Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology